Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - Zosano Pharma Corp | d479354dex51.htm |
| S-1/A - AMENDMENT NO. 4 TO FORM S-1 - Zosano Pharma Corp | d479354ds1a.htm |
Exhibit 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the incorporation by reference in this Registration Statement of Zosano Pharma Corporation on Form S-1, Amendment No. 4 ( File No. 333-222265) of our report (which includes an explanatory paragraph as to the Company’s ability to continue as a going concern) dated March 12, 2018, with respect to our audits of the consolidated financial statements of Zosano Pharma Corporation as of December 31, 2017 and 2016 and for the years ended December 31, 2017 and 2016 appearing in the Annual Report on Form 10-K of Zosano Pharma Corporation for the year ended December 31, 2017. We also consent to the reference to our Firm under the heading “Experts” in the Prospectus, which is part of this Registration Statement.
/s/ Marcum LLP
Marcum LLP
Los Angeles, CA
March 26, 2018